For those living with joint pain, there’s some good news. A recent study suggests that a pill called colchicine might help ...

Dr. Jeffrey K. Moore and West Clinical Research are proud to announce the grand opening of their new clinical research site, ...

CALGARY, Alberta, Jan. 29, 2025 (GLOBE NEWSWIRE) -- ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA) ...

Among patients with gout in the US, Black individuals and those living in the South were associated with reduced adherence to allopurinol.

A recent study by researchers from the University of California San Diego and collaborators has uncovered a new molecular ...

In addition to ZTlido, Scilex's portfolio features Elyxyb, an oral celecoxib solution for migraines, which may also find broader use for acute pain such as tension headaches. Another product ...

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. | Following some ...

Rheumatologists report largely adhering to American College of Rheumatology guidelines for gout management, but show notable ...

PALO ALTO, Calif. - Scilex Holding Company (NASDAQ:SCLX), a $77.5 million market cap company known for its focus on non-opioid pain management products, reported that the U.S. Food and Drug ...

Emergent Major Adverse Cardiovascular and Thromboembolic Events were Infrequent During Clinical Trials of Pegloticase,” published in the January 2025 issue of Rheumatology by Troum et al. Maintaining ...

About XORTX Therapeutics Inc. XORTX is a pharmaceutical company with three clinically advanced products in development: 1) our lead, XRx-008 program for ADPKD; 2) our XRx-026 program for the treatment ...

Gloperba® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.Over 70% of gout patients have comorbid ...